Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9676
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.date.accessioned2022-07-29T17:55:10Z-
dc.date.available2022-07-29T17:55:10Z-
dc.date.issued2011-11-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/9676-
dc.subjectAntineoplásicospt_BR
dc.subjectAntineoplastic Agentspt_BR
dc.subjectPolítica de Inovação e Desenvolvimentopt_BR
dc.subjectInnovation and Development Policypt_BR
dc.subjectPolítica de Innovación y Desarrollopt_BR
dc.titleMS cria Rede Nacional de Desenvolvimento e Inovação de Fármacos Anticâncerpt_BR
dc.title.alternativeInforme INCA 294pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 294

Files in This Item:
File Description SizeFormat 
Informe INCA 294-11.pdf48.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.